NIT1
Deaminated glutathione amidase
Also known as: NIT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86X76
- Gene
- NIT1
- Ensembl
- ENSG00000158793
- Chromosome
- 1
- Canonical length
- 327 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
This gene encodes a member of the nitrilase protein family with homology to bacterial and plant nitrilases, enzymes that cleave nitriles and organic amides to the corresponding carboxylic acids plus ammonia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q86X76|NIT1
1 MLGFITRPPH RFLSLLCPGL RIPQLSVLCA QPRPRAMAIS SSSCELPLVA VCQVTSTPDK
61 QQNFKTCAEL VREAARLGAC LAFLPEAFDF IARDPAETLH LSEPLGGKLL EEYTQLAREC
121 GLWLSLGGFH ERGQDWEQTQ KIYNCHVLLN SKGAVVATYR KTHLCDVEIP GQGPMCESNS
181 TMPGPSLESP VSTPAGKIGL AVCYDMRFPE LSLALAQAGA EILTYPSAFG SITGPAHWEV
241 LLRARAIETQ CYVVAAAQCG RHHEKRASYG HSMVVDPWGT VVARCSEGPG LCLARIDLNY
301 LRQLRRHLPV FQHRRPDLYG NLGHPLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NIT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- liver: 55 nTPM
- adrenal gland: 53 nTPM
- kidney: 35 nTPM
- choroid plexus: 29 nTPM
- small intestine: 28 nTPM
- parathyroid gland: 28 nTPM
Single-cell type
- oocytes: 166 nCPM
- late primary spermatocytes: 154 nCPM
- late spermatids: 142 nCPM
- enterocytes: 106 nCPM
- megakaryocytes: 105 nCPM
- platelets: 97 nCPM
Immune cell
- basophil: 43 nTPM
- non-classical monocyte: 26 nTPM
- classical monocyte: 20 nTPM
- eosinophil: 19 nTPM
- intermediate monocyte: 19 nTPM
- plasmacytoid DC: 18 nTPM
Brain region
- choroid plexus: 26 nTPM
- pons: 25 nTPM
- thalamus: 24 nTPM
- hypothalamus: 24 nTPM
- medulla oblongata: 24 nTPM
- white matter: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NIT1.
Disease | AllUniProt
Conditions NIT1 is implicated in, by any mechanism.
- Brain small vessel disease 4 (BSVD4) MIM:621313
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 83 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Susceptibility to severe COVID-19
- Brain small vessel disease 4
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.6
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- deaminated glutathione amidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Carbon-nitrogen hydrolase
- Carbon-nitrogen hydrolase superfamily
- Nit1/2, carbon-nitrogen hydrolase domain
- Carbon-nitrogen hydrolase
- Uncharacterised protein family UPF0012, conserved site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NIT1 as an antibody target. Whether an autoantibody or antibody against NIT1 could matter depends on whether native NIT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NIT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NIT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...